Lactotransferrin Downregulation Serves as a Potential Predictor for the Therapeutic Effectiveness of mTOR Inhibitors in the Metastatic Clear Cell Renal Cell Carcinoma without PTEN Mutation

Approximately 30% of clear cell renal cell carcinoma (ccRCC) patients develop metastatic spread at the first diagnosis. Therefore, identifying a useful biomarker to predict ccRCC metastasis or therapeutic effectiveness in ccRCC patients is urgently needed. Previously, we demonstrated that lactotrans...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jing-Quan, Lin, Che-Hsuan, Lee, Hsun-Hua, Wang, Wen-Ke, Tong, Yiu-Shun, Lee, Kang-Yun, Chiu, Hui-Wen, Lin, Yuan-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698394/
https://www.ncbi.nlm.nih.gov/pubmed/34944711
http://dx.doi.org/10.3390/biomedicines9121896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698394/
https://www.ncbi.nlm.nih.gov/pubmed/34944711
http://dx.doi.org/10.3390/biomedicines9121896

Ejemplares similares